Back

Atrial fibrillation is an independent determinant of mortality and resource utilisation in hospitalised multiple myeloma patients

20 June 2026 (09:45 - 10:30)
Organised by: Logo
Congress Presentation Part of: Special populations in cardio-oncology: who is most at risk - and why it matters long term Diagnosis and Management of Cardiovascular Disease in Patients with Cancer Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Mr Adam Bolad

Zionsville (United States of America)

5 More presentations in this session

Presentation thumbnail
Impact of cardiovascular complications on survival following hematopoietic stem cell transplantation
Doctor V. Cetoretta (Ancona, IT) Doctor A. Fazeli (Ancona, IT)
Abstract Slides
Presentation thumbnail
Cardiovascular complications after contemporary allogeneic haematopoietic stem cell transplantation
Doctor M. Murati (Florence, IT)
Abstract Slides
Presentation thumbnail
Early cancer therapy-related cardiovascular toxicities in children and adolescents: incidence and risk factors within five years from diagnosis
Doctor F. Guida (Bologna, IT)
Abstract Slides
Presentation thumbnail
Impact of adjuvant hormone therapy on cardiac function and lipid profiles in breast cancer patients: a prospective cohort study
Associate Professor H. Park (Hwasun, KR)
Abstract Slides
Presentation thumbnail
Long-term outcomes after surgical resection of atrial myxoma: a 13-year experience at a tertiary referral centre
Mr P. Cannon (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Special populations in cardio-oncology: who is most at risk - and why it matters long term

The Event

Event poster

ESC Cardio-Oncology 2026

20 June 2026 09:45 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources